Jardiance (empagliflozin) works by blocking a protein in your kidneys that normally reabsorbs sugar back into your bloodstream. With that protein blocked, excess glucose leaves your body through urine instead of recirculating. On the 10 mg dose, patients excrete an average of 64 grams of glucose per day; on the 25 mg dose, about 78 grams per day. That’s the equivalent of flushing roughly 250 to 300 calories down the toilet daily.
The Kidney Mechanism Behind Jardiance
Your kidneys filter your blood thousands of times a day. As that filtered fluid passes through tiny tubes called proximal tubules, a transporter protein called SGLT2 pulls glucose and sodium out of the fluid and sends them back into your blood. In healthy people, this recycling makes sense: you don’t want to lose valuable fuel. But in type 2 diabetes, the system works too aggressively, reclaiming too much sugar and contributing to high blood glucose levels.
Jardiance selectively blocks SGLT2. With that transporter inhibited, a significant portion of filtered glucose stays in the tubule fluid and exits through urine. The effect begins immediately after the first dose and remains consistent over weeks of treatment. Because the drug targets the kidney rather than insulin-producing cells in the pancreas, it lowers blood sugar through an entirely different pathway than most other diabetes medications.
How It Protects the Kidneys
In diabetes, the kidneys often work harder than they should. Overactive sugar and sodium reabsorption in the proximal tubule tricks a feedback sensor deeper in the kidney (called the macula densa) into thinking too little fluid is flowing through. The kidney responds by opening up blood flow into its filters, creating excess pressure inside each filtering unit. Over years, that high pressure damages the delicate filtering membranes, which is how diabetes leads to chronic kidney disease.
Jardiance reverses this chain of events. By blocking sodium and glucose reabsorption upstream, more fluid reaches the macula densa. That sensor then triggers its normal feedback response: tightening blood flow into the filter and reducing the pressure inside it. The result is that each filtering unit handles a more manageable workload. This correction of “hyperfiltration” is one of the main reasons Jardiance slows kidney damage in people with diabetes, independent of its blood sugar effects.
Cardiovascular Benefits
Jardiance gained attention for its heart-protective effects after the EMPA-REG OUTCOME trial, one of the largest cardiovascular studies ever conducted with a diabetes drug. In patients with type 2 diabetes who already had cardiovascular disease, empagliflozin reduced the risk of cardiovascular death by 38%, hospitalization for heart failure by 35%, and death from any cause by 32%, compared to placebo. These results were striking because they appeared within months, far too quickly to be explained by gradual improvements in blood sugar or cholesterol alone.
Several mechanisms likely contribute. The drug causes a mild but persistent loss of sodium and water through urine, which reduces blood volume and lowers blood pressure. In clinical studies, empagliflozin lowered 24-hour systolic blood pressure by roughly 5 mmHg at 12 weeks and over 8 mmHg at 24 weeks. That volume reduction takes strain off the heart, especially in patients with heart failure where excess fluid is a core problem. The drug also shifts the heart’s fuel source: with less glucose available in the blood and more leaving through urine, the heart relies more on ketones and fatty acids, which some researchers believe are more efficient fuels for a struggling heart muscle.
Effects on Weight and Blood Pressure
Because Jardiance forces your body to excrete glucose (and the calories it contains), modest weight loss is a consistent side effect. In 24-week clinical studies, patients on the 10 mg dose lost an average of 2.8% of their body weight, while those on 25 mg lost about 3.2%. For a 200-pound person, that translates to roughly 5.5 to 6.5 pounds. Most of this weight loss occurs in the first few months and then stabilizes. It’s real fat and fluid loss, not muscle wasting, though it’s not dramatic enough to replace dedicated weight loss strategies.
The blood pressure reduction comes partly from the same mechanism. When glucose leaves through urine, it pulls water with it through osmosis, creating a mild diuretic effect. This reduces the volume of fluid in your circulation and lowers the pressure your blood vessels have to handle. Unlike traditional diuretics, Jardiance achieves this without forcing large amounts of potassium out of your body.
Common Side Effects
The most distinctive side effect of Jardiance is an increased risk of genital yeast infections, a direct consequence of having more sugar in your urine. Yeast thrive on glucose, and the warm, moist environment of the genital area becomes an ideal breeding ground. In clinical trials, genital yeast infections occurred in about 5 to 6% of women taking Jardiance compared to 1.5% on placebo. In men, the rate was roughly 1.5 to 3% versus 0.4% on placebo. These infections are typically mild and treatable with standard antifungal medications, but they can be recurrent for some people.
Increased urination is expected given how the drug works. Most patients notice they urinate somewhat more frequently, especially in the first few weeks. Staying well-hydrated helps, and for most people the effect becomes less noticeable over time as the body adjusts.
A Rare but Serious Risk
Jardiance can, in uncommon cases, trigger a form of diabetic ketoacidosis where blood sugar stays deceptively normal (below 200 mg/dL). This is sometimes called euglycemic ketoacidosis, and it’s dangerous precisely because the normal-looking glucose reading can delay diagnosis. The body shifts into burning fat aggressively, producing acidic byproducts called ketones that accumulate in the blood.
Warning signs include nausea, vomiting, unusual fatigue, shortness of breath, rapid heartbeat, and abdominal pain. The risk increases during situations that stress the body: surgery, prolonged fasting, heavy alcohol use, or severe illness. Most prescribers recommend stopping Jardiance at least a few days before any planned surgery for this reason. If you experience these symptoms together, especially during illness or fasting, it warrants urgent medical evaluation even if your blood sugar reading looks fine.
How It Differs From Other Diabetes Drugs
Most diabetes medications work by either boosting insulin production, improving insulin sensitivity, or slowing carbohydrate absorption. Jardiance sidesteps all of these pathways entirely. It doesn’t stimulate the pancreas to make more insulin, and clinical data show no consistent effect on glucagon levels. After 24 weeks of use, fasting insulin levels actually decrease modestly compared to placebo, likely because the body needs less insulin when glucose is being removed through the kidneys.
This insulin-independent mechanism is why Jardiance carries very low risk of hypoglycemia (dangerously low blood sugar) when used alone. The kidney can only dump excess glucose; once blood sugar drops to a normal range, there’s less glucose in the filtered fluid for the drug to block, and the effect naturally tapers. Hypoglycemia risk increases only when Jardiance is combined with insulin or medications that stimulate insulin release.